Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Clinical trial NCT03935204 · COMPLETED
Trial details
- NCT number
- NCT03935204
- Sponsor
- Xiamen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2019-10-18
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.